Two-thirds (67%) of studies focused on cancer, and slightly more than one-third (38%) focused on just two types of commonly used tests (22% of studies focused on gene expression profiling tests for breast cancer and 16% on BRCA1/2 tests for breast cancer risk) (Table 2). This evidence concerns the gene BRCA1 and breast carcinoma.